Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Urology. 2014 May 10;84(1):127–131. doi: 10.1016/j.urology.2014.03.015

Table 1.

Demographics and characteristics of men with prostate cancer by TMPRSS2:ETS status of the PCPT study participants.

All (n=195) TMPRSS2:ETS positive (n=97) TMPRSS2:ETS Negative (n=98) p-value
Mean (SD)
Age at Baseline (y) 60.44 (4.00) 60.02 (3.84) 60.85 (4.14) 0.15
BMI (kg/m2) 27.35 (3.63) 27.35 (4.03) 27.36 (3.21) 0.99
Alcohol intake (g/d) 9.49 (14.74) 8.85 (12.88) 10.13 (16.42) 0.54
Baseline PSA (ng/dL) 2.11 (1.66) 2.06 (1.76) 2.15 (1.55) 0.72
CAG repeat length 22.0 (2.9) 21.7 (2.5) 22.3 (3.2) 0.12
n (%)
Race 0.15
 White 182 (93.33) 88 (90.72) 94 (95.92)
 Non-white 13 (6.67) 9 (9.28) 4 (4.08)
Family history 44 (22.56) 25 (25.77) 19 (19.39) 0.29
Diabetes 10 (5.13) 6 (6.19) 4 (4.08) 0.51
Treatment Arm 0.09
 Finasteride 84 (43.08) 36 (37.11) 48 (48.98)
 Placebo 111 (56.92) 61 (62.89) 50 (51.02)
Smoking Status 0.07
 Never Smoker 65 (33.33) 39 (40.21) 26 (26.53)
 Current Smoker 8 (4.10) 5 (5.15) 3 (3.06)
 Past Smoker 122 (62.56) 53 (54.64) 69 (70.41)
Physical Activity 0.90
 Sedentary 35 (18.04) 19 (19.79) 16 (16.33)
 Light 86 (44.33) 41 (42.71) 45 (45.92)
 Moderate 57 (29.38) 27 (28.13) 30 (30.61)
 Active 16 (8.25) 9 (9.38) 7 (7.14)
Gleason <0.01
 Gleason 2–6 143 (73.71) 81 (83.51) 62 (63.92)
 Gleason 7–10 51 (26.29) 16 (16.49) 35 (36.08)